Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no GVHD in leukemia patients
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients undergoing a […]
